We are live on ! Find out more
IRON icon

Disc Medicine
IRON

55 hedge funds and large institutions have $165M invested in Disc Medicine in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more call options, than puts

Call options by funds: $3.48M | Put options by funds: $1.06M

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

13% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 15

12% more funds holding

Funds holding: 49 → 55 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.02% less ownership

Funds ownership: 2% → 1.98% (-0.02%)

52% less capital invested

Capital invested by funds: $347M → $165M (-$181M)

Holders
55
Holders Change
+6
Holders Change %
+12.24%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
18
Increased
17
Reduced
15
Closed
12
Calls
$3.48M
Puts
$1.06M
Net Calls
+$2.42M
Net Calls Change
-$1.61M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$12.1M
2
BlackRock
BlackRock
New York
+$11.1M
3
SCM
Suvretta Capital Management
New York
+$9.02M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.26M
5
State Street
State Street
Massachusetts
+$3.17M

Top Sellers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
-$11M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$9.65M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.55M
4
CAM
Cormorant Asset Management
Massachusetts
-$6.44M
5
WP
Woodline Partners
California
-$3.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
51
Simplex Trading
Illinois
$6K -$539K -1,639 -98%
PHK
52
Point72 Hong Kong
Hong Kong
$4K +$6.91K +21 New
UBS Group
53
UBS Group
Switzerland
$3K -$6.58K -20 -59%
TWA
54
TCI Wealth Advisors
Arizona
$3K +$1.97K +6 +86%
AIG
55
American International Group
New York
$79 +$134K +409 New
OM
56
Opaleye Management
Massachusetts
– -$11M -27,017 Closed
T. Rowe Price Associates
57
T. Rowe Price Associates
Maryland
– -$9.65M -25,000 Closed
CAM
58
Cormorant Asset Management
Massachusetts
– -$6.44M -15,833 Closed
ACM
59
Altium Capital Management
New York
– -$2.76M -6,800 Closed
ECM
60
Endurant Capital Management
California
– -$2.3M -5,663 Closed
DCM
61
DAFNA Capital Management
California
– -$2.03M -5,000 Closed
MIM
62
Monashee Investment Management
Massachusetts
– -$1.59M -3,915 Closed
MA
63
MYDA Advisors
New York
– -$866K -2,130 Closed
IA
64
Insight Advisors
Pennsylvania
– -$454K -1,295 Closed
LP
65
LMR Partners
United Kingdom
– -$308K -758 Closed
MS
66
Maven Securities
Jersey
– -$25K -61 Closed
TCWM
67
Total Clarity Wealth Management
Illinois
– -$5K -12 Closed
1 2
3

IRON Hedge Fund Activity: Q2 2021 in Review

55 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Disc Medicine (IRON) for Q2 2021, worth a combined $165M — down 52% from $347M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new IRON positions and 12 closed out — a net gain of 6 holders — while 17 added to existing stakes and 15 trimmed.

The largest buyer was Franklin Resources, adding an estimated $12.1M. The largest seller was Opaleye Management, exiting entirely with an estimated $11M sold.

  • 55 institutional investors held Disc Medicine (IRON) as of Q2 2021, up from 49 in Q1 2021.
  • Funds reported $165M of Disc Medicine stock for Q2 2021, down 52% quarter-over-quarter.
  • 18 funds opened new Disc Medicine positions in Q2 2021 and 12 closed out, a net change of +6 holders.
  • The largest Disc Medicine buyer in Q2 2021 was Franklin Resources, an estimated $12.1M added.
  • The largest Disc Medicine seller in Q2 2021 was Opaleye Management, an estimated $11M sold.

Based on aggregated 13F filings for Q2 2021.